299 related articles for article (PubMed ID: 8231802)
1. The interaction between coumarin drugs and DNA gyrase.
Maxwell A
Mol Microbiol; 1993 Aug; 9(4):681-6. PubMed ID: 8231802
[TBL] [Abstract][Full Text] [Related]
2. The interaction of coumarin antibiotics with fragments of DNA gyrase B protein.
Gormley NA; Orphanides G; Meyer A; Cullis PM; Maxwell A
Biochemistry; 1996 Apr; 35(15):5083-92. PubMed ID: 8664301
[TBL] [Abstract][Full Text] [Related]
3. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
Neumann S; Quiñones A
J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
[TBL] [Abstract][Full Text] [Related]
4. The high-resolution crystal structure of a 24-kDa gyrase B fragment from E. coli complexed with one of the most potent coumarin inhibitors, clorobiocin.
Tsai FT; Singh OM; Skarzynski T; Wonacott AJ; Weston S; Tucker A; Pauptit RA; Breeze AL; Poyser JP; O'Brien R; Ladbury JE; Wigley DB
Proteins; 1997 May; 28(1):41-52. PubMed ID: 9144789
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of inhibition of DNA gyrase by cyclothialidine, a novel DNA gyrase inhibitor.
Nakada N; Gmünder H; Hirata T; Arisawa M
Antimicrob Agents Chemother; 1994 Sep; 38(9):1966-73. PubMed ID: 7811004
[TBL] [Abstract][Full Text] [Related]
6. Mycobacterial DNA gyrase: enzyme purification and characterization of supercoiling activity.
Wu LC; Shahied SI
Arch Biochem Biophys; 1995 Dec; 324(1):123-9. PubMed ID: 7503546
[TBL] [Abstract][Full Text] [Related]
7. gyrB mutations which confer coumarin resistance also affect DNA supercoiling and ATP hydrolysis by Escherichia coli DNA gyrase.
Contreras A; Maxwell A
Mol Microbiol; 1992 Jun; 6(12):1617-24. PubMed ID: 1323022
[TBL] [Abstract][Full Text] [Related]
8. Novobiocin and related coumarins and depletion of heat shock protein 90-dependent signaling proteins.
Marcu MG; Schulte TW; Neckers L
J Natl Cancer Inst; 2000 Feb; 92(3):242-8. PubMed ID: 10655441
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationship in two series of aminoalkyl substituted coumarin inhibitors of gyrase B.
Laurin P; Ferroud D; Schio L; Klich M; Dupuis-Hamelin C; Mauvais P; Lassaigne P; Bonnefoy A; Musicki B
Bioorg Med Chem Lett; 1999 Oct; 9(19):2875-80. PubMed ID: 10522710
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the binding site for cyclothialidine on the B subunit of DNA gyrase.
Nakada N; Gmünder H; Hirata T; Arisawa M
J Biol Chem; 1995 Jun; 270(24):14286-91. PubMed ID: 7782285
[TBL] [Abstract][Full Text] [Related]
11. DNA gyrase activities from Rhodobacter capsulatus: analysis of target(s) of coumarins and cloning of the gyrB locus.
Kranz RG; Beckman DL; Foster-Hartnett D
FEMS Microbiol Lett; 1992 May; 72(1):25-32. PubMed ID: 1319375
[TBL] [Abstract][Full Text] [Related]
12. Effects of novobiocin, coumermycin A1, clorobiocin, and their analogs on Escherichia coli DNA gyrase and bacterial growth.
Hooper DC; Wolfson JS; McHugh GL; Winters MB; Swartz MN
Antimicrob Agents Chemother; 1982 Oct; 22(4):662-71. PubMed ID: 6295263
[TBL] [Abstract][Full Text] [Related]
13. Active-site residues of Escherichia coli DNA gyrase required in coupling ATP hydrolysis to DNA supercoiling and amino acid substitutions leading to novobiocin resistance.
Gross CH; Parsons JD; Grossman TH; Charifson PS; Bellon S; Jernee J; Dwyer M; Chambers SP; Markland W; Botfield M; Raybuck SA
Antimicrob Agents Chemother; 2003 Mar; 47(3):1037-46. PubMed ID: 12604539
[TBL] [Abstract][Full Text] [Related]
14. The interaction of drugs with DNA gyrase: a model for the molecular basis of quinolone action.
Heddle JG; Barnard FM; Wentzell LM; Maxwell A
Nucleosides Nucleotides Nucleic Acids; 2000 Aug; 19(8):1249-64. PubMed ID: 11097055
[TBL] [Abstract][Full Text] [Related]
15. gyrB-225, a mutation of DNA gyrase that compensates for topoisomerase I deficiency: investigation of its low activity and quinolone hypersensitivity.
Heddle JG; Lu T; Zhao X; Drlica K; Maxwell A
J Mol Biol; 2001 Jun; 309(5):1219-31. PubMed ID: 11399091
[TBL] [Abstract][Full Text] [Related]
16. DNA gyrase and the supercoiling of DNA.
Cozzarelli NR
Science; 1980 Feb; 207(4434):953-60. PubMed ID: 6243420
[TBL] [Abstract][Full Text] [Related]
17. Streptococcus pneumononiae gyrase ATPase: development and validation of an assay for inhibitor discovery and characterization.
Miller JR; Herberg JT; Tomilo M; McCroskey MC; Feilmeier BJ
Anal Biochem; 2007 Jun; 365(1):132-43. PubMed ID: 17395144
[TBL] [Abstract][Full Text] [Related]
18. Energy coupling in DNA gyrase and the mechanism of action of novobiocin.
Sugino A; Higgins NP; Brown PO; Peebles CL; Cozzarelli NR
Proc Natl Acad Sci U S A; 1978 Oct; 75(10):4838-42. PubMed ID: 368801
[TBL] [Abstract][Full Text] [Related]
19. The 43-kilodalton N-terminal fragment of the DNA gyrase B protein hydrolyzes ATP and binds coumarin drugs.
Ali JA; Jackson AP; Howells AJ; Maxwell A
Biochemistry; 1993 Mar; 32(10):2717-24. PubMed ID: 8383523
[TBL] [Abstract][Full Text] [Related]
20. Effects of DNA gyrase inhibitors in Escherichia coli topoisomerase I mutants.
Pruss GJ; Franco RJ; Chevalier SG; Manes SH; Drlica K
J Bacteriol; 1986 Oct; 168(1):276-82. PubMed ID: 3019999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
